Regulatory role of regucalcin in heart calcium signaling: Insight into cardiac failure (Review)
Open Access
- 5 March 2014
- journal article
- Published by Spandidos Publications in Biomedical Reports
- Vol. 2 (3) , 303-308
Abstract
Regucalcin was first identified in 1978 as a regulatory protein of Ca2+ signaling in liver cells. Regucalcin was shown to play a multifunctional role in cell regulation, such as maintainance of intracellular Ca2+ homeostasis and suppression of signal transduction, protein synthesis, nuclear function, cell proliferation and apoptosis in various types of cells and tissues. Cardiac excitation‑contraction coupling is based on the regulation of intracellular Ca2+ concentration by the Ca2+ pump in the sarcoplasmic reticulum of heart muscle cells. Regucalcin, which is expressed in the heart, was found to increase rat heart sarcoplasmic reticulum Ca2+‑ATPase activity and ATP‑dependent Ca2+ uptake and mitochondrial Ca2+‑ATPase activity. Regucalcin was also shown to suppress Ca2+‑dependent protein tyrosine phosphatase, Ca2+/calmodulin‑dependent protein phosphatase (calcineurin) and nitric oxide (NO) synthase activity in the heart cytoplasm. Moreover, regucalcin was found to activate superoxide dismutase (SOD), which plays a significant role in the prevention of cell death and apoptosis in the heart. Regucalcin may be a key molecule in heart muscle cell regulation through Ca2+ signaling. Regucalcin may also play a pathophysiological role in heart failure. The aim of this study was to review the recent findings regarding the role of regucalcin in Ca2+ signaling in the heart.Keywords
This publication has 39 references indexed in Scilit:
- The anti-apoptotic effect of regucalcin is mediated through multisignaling pathwaysApoptosis, 2013
- Inhibition of spontaneous activity of rabbit atrioventricular node cells by KB-R7943 and inhibitors of sarcoplasmic reticulum Ca2+ ATPaseCell Calcium, 2011
- Role of regucalcin as an activator of sarcoplasmic reticulum Ca2+-ATPase activity in rat heart muscleJournal of Cellular Biochemistry, 2002
- An Integrated, Functionally Annotated Gene Map of the DXS8026–ELK1 Interval on Human Xp11.3–Xp11.23: Potential Hotspot for Neurogenetic DisordersGenomics, 2002
- Role of endogenous regucalcin in transgenic rats: Suppression of kidney cortex cytosolic protein phosphatase activity and enhancement of heart muscle microsomal Ca2+‐ATPase activityJournal of Cellular Biochemistry, 2002
- Genomic cloning and chromosomal assignment of rat regucalcin geneMolecular and Cellular Biochemistry, 1995
- Molecular cloning and sequencing of the cDNA coding for a calcium‐binding protein regucalcin from rat liverFEBS Letters, 1993
- Immunohistochemical Demonstration of Calcium-Binding Protein Regucalcin in the Tissues of Rats: The Protein Localizes in Liver and Brain.Chemical and Pharmaceutical Bulletin, 1991
- Effects of Ca2+ and Zn2+ on 5'-nucleotidase activity in rat liver plasma membranes: Hepatic calcium-binding protein (regucalcin) reverses the Ca2+ effect.Chemical and Pharmaceutical Bulletin, 1988
- Purification of calcium binding substance from soluble fraction of normal rat liver.Chemical and Pharmaceutical Bulletin, 1978